Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane-bound D-lactate dehydrogenase (D-iLDH), specifically the quinone-dependent form (EC 1.1.5.12), is a flavoprotein essential for the utilization of D-lactate as a primary carbon and energy source in many bacteria (UniProt: P00361). It is located on the cytoplasmic surface of the inner membrane and facilitates the oxidation of D-lactate to pyruvate, transferring electrons directly to the respiratory quinone pool (PubMed: 15686558). This process is vital for maintaining the proton motive force and ATP production in pathogens like Escherichia coli and Staphylococcus aureus (PubMed: 28844881). Since humans primarily utilize L-lactate and possess a structurally distinct mitochondrial D-lactate dehydrogenase, this bacterial enzyme represents a promising target for narrow-spectrum antibiotics (PubMed: 31265111). Inhibiting D-iLDH can effectively starve bacteria of energy in lactate-rich environments, such as abscesses or the gut (PubMed: 25631484). Current therapeutic research focuses on small-molecule inhibitors that can selectively bind the bacterial enzyme's active site without cross-reacting with human metabolic pathways (PubMed: 18439557).
Inhibition of the oxidation of D-lactate to pyruvate, which prevents electron transfer to the quinone pool, thereby disrupting the bacterial respiratory chain and ATP generation (PubMed: 28844881).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-lactate dehydrogenase (quinone) (D-iLDH).